Conseil consultatif sur la recherche (CCR)


PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output

In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

David Berman, Queen's Cancer Research Institute, Kingston, ON
Paul Boutros, Ontario Institute for Cancer Research (OICR)
, Toronto, ON
Ralph Buttyan, Vancouver Prostate Centre, Vancouver, BC
Kim Chi, BC Cancer Agency, Vancouver, BC
Michael Cox, University of British Columbia, Vancouver, BC

Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto, ON
Carolyn Gotay, University of British Columbia, Vancouver, BC
Masoom Haider, Sunnybrook Research Institute, Toronto
, ON
Winston Klass, Community Representative, Concord, ON
John Lewis, University of Alberta, Edmonton, AB
Randy Mellow, Community Representative, Peterborough, ON

Ian G Mills, Queen's University Belfast, Belfast, UK
John Oliffe, University of British Columbia, Vancouver
, BC
Marie-Elise Parent, INRS–Institut Armand-Frappier Research Centre, Laval, QC
Fred Saad, Université de Montréal, Montreal, QC
Gurmit Singh (président), McMaster University, Hamilton, ON

John Valliant, McMaster University, Hamilton, ON
Danny Vesprini, Sunnybrook Research Institute, Toronto, ON

17 juin 2016




Inscrivez-vous à nos nouvelles

* obligatoire






 
Contenu en vedette
Rocco Rossi conclut un mandat réussi de cinq ans à titre de président et chef de la direction de Cancer de la Prostate Canada

7 septembre 2017 - TORONTO (ONTARIO) - C’est avec beaucoup d’émotion que le président et chef de la direction de longue date de Cancer de la Prostate Canada (CPC), Rocco Rossi, a officiellement annoncé aujourd’hui qu’il quittera ses fonctions à la barre de l’organisation le 31 décembre 2017.
plus

La Fondation Movember et Cancer de la Prostate Canada font équipe pour transformer la recherche en résultats

26 juillet 2017 – TORONTO (ONTARIO) – Fidèles à leur longue tradition de partenariat pour le financement de recherches de grande qualité sur le cancer de la prostate au Canada, Cancer de la Prostate Canada (CPC) et la Fondation Movember ont annoncé aujourd’hui deux nouveaux projets qui offrent un potentiel très réel de changer concrètement le cours des choses pour les hommes atteints de formes virulentes du cancer de la prostate.
plus


Cancer de la prostate nouvelles